Hong, Hang
Tang, Chunlan
Liu, Yuhui
Jiang, Haibo
Fang, Ting
Xu, Guozhang
Funding for this research was provided by:
Zhejiang Medical and Health Technology Discipling (2021KY1017)
Natural Science Foundation of Zhejiang Province (LQ20H260005)
Ningbo Health Branding Subject Fund (PPXK2018-10)
Key Discipline of Zhejiang Province in Medical Technology (07-013)
Article History
Received: 20 July 2023
Accepted: 25 September 2023
First Online: 13 October 2023
Declarations
:
: The authors declare no competing interests.
: The study protocol was reviewed and approved by the Institutional Review Board of the Ningbo CDC in China (201706 and 201908). Participants provided written informed consent to use sequencing data both for HIV drug resistance and genetic transmission network studies.
: Not applicable.